Trusted by:
A common heart drug may stop the progression of angiosarcoma, a cancer of the inner lining of blood vessels, according to a study by researchers at Texas Tech University Health Sciences Center (TTUHSC) El Paso.
EL PASO, Texas 鈥� Children who lived in Juarez, Mexico 鈥� once dubbed the murder capital of the world 鈥� in 2010 have high levels of behavioral and emotional problems, according to new research by Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso).
A natural extract derived from India鈥檚 neem tree could potentially be used to treat pancreatic cancer, according to a new study in the journal Scientific Reports.
Neuroscientists have discovered a specific enzyme that plays a critical role in spinal muscular atrophy, and that suppressing this enzyme鈥檚 activity, could markedly reduce the disease鈥檚 severity and improve patients鈥� lifestyles.
Scientists have developed a process that improves the efficiency of CRISPR, an up-and-coming technology used to edit DNA.
Inconsistencies across studies and sampling errors remain major barriers to understanding how the lung microbiome changes with tuberculosis, according to a review published today in Clinical Microbiology Reviews.
EL PASO, Texas - Certain symptoms associated with the development of Alzheimer鈥檚 disease, including agitation and depression, affect Hispanics more frequently and severely than other ethnicities. The findings, published in the Journal of Neuropsychiatry and Clinical Neuroscience (JNCN), suggest that Alzheimer鈥檚 disease manifests itself differently in Hispanic populations.
Peter Rotwein, M.D., was recently spotlighted by the American Society for Biochemistry and Molecular Biology (ASBMB) for a study he conducted on insulin-like growth factors (IGFs), a family of proteins that are crucial in early human growth and development. IGF mutations have been tied to dire health problems, like growth failure, intellectual deficiencies, and other developmental abnormalities.
鈥淓ureka鈥� moments still happen in scientific research. David P. Cistola, MD, PhD, had his moment in August 2014 when he and his research team discovered a blood biomarker that identifies individuals who could be at risk for Type 2 diabetes and prediabetes. That discovery could revolutionize how the early changes that lead to diabetes are detected鈥攇iving patients the opportunity to make lifestyle modifications or initiate therapies that prevent the disease from developing in the first place.
In addition to his role at TTUHSC El Paso, Dr. Edwards is a practicing internist at Texas Tech Physicians of El Paso where he delivers world-class patient care at its Alberta location. He specializes in diabetes mellitus, high blood pressure, high cholesterol, chronic kidney disease, chronic liver disease, osteoporosis, osteoarthritis, joint pain, lower back pain, chronic heart disease, seasonal allergies, upper respiratory infections, hypothyroidism, preventative health care, urinary tract infections, depression, heartburn (GERD), asthma and chronic obstructive pulmonary disease (COPD).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 麻豆传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right